Pacira Pharmaceuticals, Inc. - NASDAQ: PCRX


About

Controlling postsurgical pain is the key to improving patient outcomes, yet up to 80% of patients report pain that is moderate to extreme in intensity after surgery.

Our in-depth knowledge of the needs of the postsurgical pain market, coupled with our passion for delivering improved patient care, drives our commitment to providing solutions that address unmet medical needs and improve clinical results. .

Contact

5 Sylvan Way
Parsippany, New Jersey 07054
United States

Get Directions

Upgrade Your Listing

Contact

973-254-3560


Bookmarking
Bookmark this